drug
The drug has been shown to improve glycaemic control in       patients with type 2 diabetes mellitus when used as monotherapy or in combination       with other oral antidiabetic drugs or insulin, and its efficacy is similar to       that of glibenclamide or metformin.
The  @SUBJECT$  has been shown to improve glycaemic control  @PREDICAT$         @OBJECT$  with type 2 diabetes mellitus when used as monotherapy or in combination       with other oral antidiabetic drugs or insulin, and its efficacy is similar to       that of glibenclamide or metformin.